Related Experiment Video
Updated: Aug 6, 2026
10:22
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
Mast Cell Activation Profiles in Perioperative Immediate Hypersensitivity Reactions: A GERAP Network Study
Charles Tacquard1,2, Julien Serrier3,4, Aurélie Gouel-Chéron5,6
1Department of Anesthesia and Intensive Care, Strasbourg University Hospital, Strasbourg France.
Summary
Perioperative hypersensitivity reactions have varied mast cell activation (MCA) profiles. High tryptase-MCA reactions were more severe, but current tests still limit definitive mechanism identification.
Area of Science:
- Anesthesiology
- Immunology
- Allergy
Background:
- Perioperative immediate hypersensitivity reactions (POHRs) are severe anesthetic complications.
- Mast cell activation (MCA) is a key factor, but tryptase has diagnostic limits.
- Understanding POHRs' mechanisms and phenotypes is crucial for management.
Purpose of the Study:
- To compare POHR patient phenotypes based on MCA profiles.
- To utilize tryptase and histamine assays for MCA profiling.
- To correlate clinical characteristics with MCA profiles in POHRs.
Main Methods:
- Retrospective multicenter study (2017-2024) of POHR patients.
- MCA profiles defined by tryptase levels (LT vs. HT) and histamine release.
- Analysis of clinical data and biomarker correlations across MCA profiles.
Main Results:
- 67% of patients showed MCA; High Tryptase-MCA (HT-MCA) and Low Tryptase-NoMCA (LT-NoMCA) were most common.
- POHRs were significantly more severe in the HT-MCA group (85%) vs. LT-NoMCA (43%).
- Some patients had histamine release only; MCA profiles varied by perioperative drugs, suggesting diverse mechanisms.
Conclusions:
- While high tryptase-MCA often suggests IgE-mediated reactions, definitive mechanism identification remains challenging.
- Current diagnostic tools in clinical practice have limitations in precisely identifying POHR mechanisms.
- Further research is needed to improve diagnostic certainty for POHRs.
